Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors by Oldenburg Jan, Kraggerud Sigrid M, Cvancarova Milada, Lothe Ragnhild A, Fossa Sophie D in Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2007).

[PMID: 17228018] PubMed


Cisplatin, a cornerstone of combination chemotherapy in the treatment of testicular cancer, induces hearing impairment with considerable interindividual variations. These differences might be a result of functional polymorphisms in cisplatin-detoxifying enzymes like glutathione S-transferases (GSTs).

[ hide abstract ]

Discussed In Paper


Variant Annotations

Sign in to see variant annotations.

Rx Annotations

No dosing information annotated.